These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The Psychopharmacology of ±3,4 Methylenedioxymethamphetamine and its Role in the Treatment of Posttraumatic Stress Disorder. Amoroso T J Psychoactive Drugs; 2015; 47(5):337-44. PubMed ID: 26579955 [TBL] [Abstract][Full Text] [Related]
3. The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. Mithoefer MC; Wagner MT; Mithoefer AT; Jerome L; Doblin R J Psychopharmacol; 2011 Apr; 25(4):439-52. PubMed ID: 20643699 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of serotonin transporters disrupts the enhancement of fear memory extinction by 3,4-methylenedioxymethamphetamine (MDMA). Young MB; Norrholm SD; Khoury LM; Jovanovic T; Rauch SAM; Reiff CM; Dunlop BW; Rothbaum BO; Howell LL Psychopharmacology (Berl); 2017 Oct; 234(19):2883-2895. PubMed ID: 28741031 [TBL] [Abstract][Full Text] [Related]
5. Progress and promise for the MDMA drug development program. Feduccia AA; Holland J; Mithoefer MC Psychopharmacology (Berl); 2018 Feb; 235(2):561-571. PubMed ID: 29152674 [TBL] [Abstract][Full Text] [Related]
6. The entactogen 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) as a treatment aid in psychotherapy and its safety concerns. Baldo BA Arch Toxicol; 2024 Aug; 98(8):2409-2427. PubMed ID: 38743292 [TBL] [Abstract][Full Text] [Related]
7. MDMA-Assisted Psychotherapy for Treatment of Posttraumatic Stress Disorder: A Systematic Review With Meta-Analysis. Smith KW; Sicignano DJ; Hernandez AV; White CM J Clin Pharmacol; 2022 Apr; 62(4):463-471. PubMed ID: 34708874 [TBL] [Abstract][Full Text] [Related]
9. MDMA and PTSD treatment: "PTSD: From novel pathophysiology to innovative therapeutics". Sessa B Neurosci Lett; 2017 May; 649():176-180. PubMed ID: 27394687 [TBL] [Abstract][Full Text] [Related]
10. The psychotherapeutic potential of MDMA (3,4-methylenedioxymethamphetamine): an evidence-based review. Parrott AC Psychopharmacology (Berl); 2007 Apr; 191(2):181-93. PubMed ID: 17297639 [TBL] [Abstract][Full Text] [Related]
11. Treating posttraumatic stress disorder and alcohol use disorder comorbidity: Current pharmacological therapies and the future of MDMA-integrated psychotherapy. Gully BJ; Eaton E; Capone C; Haass-Koffler CL J Psychopharmacol; 2023 Dec; 37(12):1182-1189. PubMed ID: 38009477 [TBL] [Abstract][Full Text] [Related]
12. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. Mithoefer MC; Mithoefer AT; Feduccia AA; Jerome L; Wagner M; Wymer J; Holland J; Hamilton S; Yazar-Klosinski B; Emerson A; Doblin R Lancet Psychiatry; 2018 Jun; 5(6):486-497. PubMed ID: 29728331 [TBL] [Abstract][Full Text] [Related]
13. Psilocybin and MDMA for the treatment of trauma-related psychopathology. Bird CIV; Modlin NL; Rucker JJH Int Rev Psychiatry; 2021 May; 33(3):229-249. PubMed ID: 34121583 [TBL] [Abstract][Full Text] [Related]
14. Why MDMA therapy for alcohol use disorder? And why now? Sessa B Neuropharmacology; 2018 Nov; 142():83-88. PubMed ID: 29126911 [TBL] [Abstract][Full Text] [Related]
15. The efficacy and safety of MDMA-assisted psychotherapy for treatment of posttraumatic stress disorder: A systematic review and meta-analysis from randomized controlled trials. Yang J; Wang N; Luo W; Gao J Psychiatry Res; 2024 Sep; 339():116043. PubMed ID: 38896930 [TBL] [Abstract][Full Text] [Related]
16. Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy. Oeri HE J Psychopharmacol; 2021 May; 35(5):512-536. PubMed ID: 32909493 [TBL] [Abstract][Full Text] [Related]
17. The cost-effectiveness of MDMA-assisted psychotherapy for the treatment of chronic, treatment-resistant PTSD. Marseille E; Kahn JG; Yazar-Klosinski B; Doblin R PLoS One; 2020; 15(10):e0239997. PubMed ID: 33052965 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy. Wagner MT; Mithoefer MC; Mithoefer AT; MacAulay RK; Jerome L; Yazar-Klosinski B; Doblin R J Psychopharmacol; 2017 Aug; 31(8):967-974. PubMed ID: 28635375 [TBL] [Abstract][Full Text] [Related]
19. Will MDMA-assisted psychotherapy become a breakthrough in treatment-resistant post-traumatic stress disorder? A critical narrative review. Szafoni S; Więckiewicz G; Pudlo R; Gorczyca P; Piegza M Psychiatr Pol; 2022 Aug; 56(4):823-836. PubMed ID: 37074831 [TBL] [Abstract][Full Text] [Related]
20. Preliminary evidence for the importance of therapeutic alliance in MDMA-assisted psychotherapy for posttraumatic stress disorder. Zeifman RJ; Kettner H; Ross S; Weiss B; Mithoefer MC; Mithoefer AT; Wagner AC Eur J Psychotraumatol; 2024; 15(1):2297536. PubMed ID: 38174611 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]